**Core Concept**
Acetylcholine (ACh) is a key neurotransmitter in the parasympathetic nervous system, acting on muscarinic and nicotinic receptors to produce various physiological effects. Atropine, a muscarinic receptor antagonist, blocks the action of ACh at muscarinic receptors, leading to a competitive antagonism.

**Why the Correct Answer is Right**
Atropine exerts its effect by competitively binding to the same muscarinic receptors that ACh normally binds to. This competition reduces the ability of ACh to stimulate these receptors, resulting in a decrease in parasympathetic tone. Atropine's effect is most pronounced on the muscarinic M1 and M2 receptors found in the heart, smooth muscle, and exocrine glands. By blocking these receptors, atropine causes tachycardia, dry mouth, and decreased salivation.

**Why Each Wrong Option is Incorrect**
- **Option A:** This is incorrect because atropine does not directly stimulate the nicotinic receptors, which are primarily involved in neuromuscular transmission and autonomic ganglionic transmission.
- **Option B:** This is incorrect because atropine's primary mechanism of action is not through the inhibition of acetylcholinesterase, the enzyme responsible for breaking down ACh.
- **Option C:** This is incorrect because atropine's effect is not primarily through the stimulation of beta-adrenergic receptors, which are involved in the sympathetic nervous system.

**Clinical Pearl / High-Yield Fact**
When administering atropine, be aware that it can cause anticholinergic side effects, such as dry mouth, blurred vision, and urinary retention, especially in older patients. It's essential to monitor patients for these potential side effects, particularly in cases of prolonged use.

**Correct Answer:** D